<DOC>
	<DOCNO>NCT00624273</DOCNO>
	<brief_summary>This pilot study analyze effect sildenafil therapy digital ulcer systemic sclerosis . We want analyze ulcer heal measure size digital ulcer count analyze effect sildenafil angiography .</brief_summary>
	<brief_title>Sildenafil Treatment Digital Ulcers Patients With Systemic Sclerosis</brief_title>
	<detailed_description>INVESTIGATOR : Dr. Gabriela Riemekasten Anke Praast Prof. G. R. Burmester Prof. Falk Hiepe OBJECTIVES : Sildenafil potent drug treatment digital ulcer secondary Raynaud´s phenomenon patient connective tissue disease . Probably , sildenafil disease-modifying capability improve different sign disturb regulation vascular tone connective tissue disease . Sildenafil use long period without significant side effect scleroderma patient improve disease severity , life quality , prognosis patient connective tissue disease secondary Raynaud ` phenomenon . SUBJECTS CENTERS : We want study 10-15 patient digital ulcer secondary connective tissue diseases refractory drug , calcium channel blocker iloprost . In pilot study , patient treat Charité University Hospital . INCLUSION/EXCLUSION CRITERIA 1 . Digital gangrene , ulcer patient severe secondary Raynaud ` phenomenon 2 . Stable therapy vasoactive drug , calcium channel blocker , angiotensin inhibitors/AT II receptor antagonist pentoxifyllin 4 week treatment sildenafil . 3 . Unchanged immunosuppressive therapy 3 month treatment sildenafil 4 . No effect prostacyclin treatment , contraindication prostacyclins , reason exclude therapy EXCLUSION CRITERIA : 1 . Therapy iloprost last 4 week 2 . Sympathectomy last 4 week 3 . TIA , stroke , myocardial infarction last 6 month 4 . Instable angina pectoris 5 . Hemorrhagic diathesis , thrombocytic dysfunction , fibromuscular dysplasia 6 . Microangiopathic hemolytic anaemia 7 . Azotaemia 8 . Hypertonus adjustable diuretic , clonidine , ACE inhibitors/AT II antagonist , calcium channel blocker ) 9 . Left ventricular ejection fraction &lt; 20 % 10 . Hypotonus &lt; 80/40 mm Hg 11 . Positive pregnancy test 12 . History cancer 13 . History gastric/duodenic ulcer without endoscopic proof complete heal 14 . Participation study ( currently last 4 week ) 15 . Abuse alcohol drug , smoker 16 . Cardiac failure , use nitrate STUDY DESIGN : This open prospective pilot study one centre determine effect 6 month treatment sildenafil patient acral ulcer secondary Raynaud ` phenomenon due connective tissue disease . Drop criteria's/ final point : 1 . Any change immunomodulating suppress therapy ( e.g. , treatment cyclophosphamide alveolitis ; bolus steroid &gt; 30 mg/d ) . 2 . No response heal ulcer 4 week treatment sildenafil 3 . Manifestation new ulcers/necrosis sildenafil 4 . Escalation medication vascular influence ( calcium channel blocker , ACE inhibitors/AT II receptor blocker )</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Scleroderma , Systemic</mesh_term>
	<mesh_term>Scleroderma , Diffuse</mesh_term>
	<mesh_term>Skin Ulcer</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<criteria>1 . Digital gangrene , ulcer patient severe secondary Raynaud ` phenomenon 2 . Stable therapy vasoactive drug , calcium channel blocker , angiotensin inhibitors/AT II receptor antagonist pentoxifyllin 4 week treatment sildenafil . 3 . Unchanged immunosuppressive therapy 3 month treatment sildenafil 4 . No effect prostacyclin treatment , contraindication prostacyclins , reason exclude therapy 1 . Therapy iloprost last 4 week 2 . Sympathectomy last 4 week 3 . TIA , stroke , myocardial infarction last 6 month 4 . Instable angina pectoris 5 . Hemorrhagic diathesis , thrombocytic dysfunction , fibromuscular dysplasia 6 . Microangiopathic hemolytic anaemia 7 . Azotaemia 8 . Hypertonus adjustable diuretic , clonidine , ACE inhibitors/AT II antagonist , calcium channel blocker ) 9 . Left ventricular ejection fraction &lt; 20 % 10 . Hypotonus &lt; 80/40 mm Hg 11 . Positive pregnancy test 12 . History cancer 13 . History gastric/duodenic ulcer without endoscopic proof complete heal 14 . Participation study ( currently last 4 week ) 15 . Abuse alcohol drug , smoker 16 . Cardiac failure , use nitrate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2003</verification_date>
	<keyword>digital ulcer ,</keyword>
	<keyword>systemic sclerosis ,</keyword>
	<keyword>sildenafil ,</keyword>
	<keyword>vasoactive therapy</keyword>
</DOC>